Publication dates

Influenza Vaccine Industry, October 2014 Market Reports from Top Publishers

You might be interested in: vaccine, influenza, therapeutics


 
1-10 of 74 reports for Influenza Vaccine

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... For critical-care biopharmaceuticals, biotechnology and pharmaceutical companies. Its products include ivig, albumin, coagulation products, influenza vaccines, hyperimmune globulins, igim, serine protease ...

Glide Pharmaceutical Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

Glide Pharmaceutical Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... The company offers pre-clinical development program such as glide octreotide, glide parathyroid hormone, anthrax vaccine and glide influenza vaccine. It uses glide sdi, a patented drug delivery system ...

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Applications. It offers products such as vaccines, and biotherapeutics. Ibio offers vaccines such as influenza vaccines, malaria, hookworm, yellow fever, human papilloma virus, and bacterial pathogens ...

Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Partners, u.S. Department of defense (darpa), path grant, infectious disease research institute (idri), and u.S. Army research for commercial development of influenza vaccines. Medicago is headquartered ...

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Xen for vaccine delivery and oncohist. Its polyxen products include erepoxen, sulixen, pulmoxen and psa-rfviii cand. Xenetic also provides imuxen products such as myeloxen, influenza vaccine cand and hiv ...

BiondVax Pharmaceuticals Ltd. (BNDX) - Financial and Strategic SWOT Analysis Review

BiondVax Pharmaceuticals Ltd. (BNDX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And manufactures universal flu (influenza) vaccine to provide multi-strain, multi-season and long-term protection against various flu viruses. It has completed two phase i/ii clinical trials for the multimeric-001 ...

Hualan Biological Engineering, Inc. (Symbol:002007) SWOT Analysis, Strategy, Revenues and Profits

Hualan Biological Engineering, Inc. (Symbol:002007) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And surgical lyophilized fibrin sealant. Hualan biological offers vaccines, such as inactivated influenza vaccine, recombinant hepatitis b vaccine, meningococcal polysaccharide vaccine group acyw135 ...

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Such as vaccines, diagnostics, and biological products. The company's vaccine products include japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It provides services ...

Global H1N1 Vaccines Market 2014-2018

Global H1N1 Vaccines Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

... Asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. influenza vaccines are administered for active immunization against influenza virus. This, in turn ...

Biopharmaceutical Industry: AlphaVax, Inc. – Product Pipeline Review – Q2 2011

Biopharmaceutical Industry: AlphaVax, Inc. – Product Pipeline Review – Q2 2011

  • $ 1 500
  • Industry report
  • September 2014
  • by Global Markets Direct

... Product description 23mechanism of action 23r&d progress 23pandemic influenza vaccine 24product description 24mechanism of action 24r&d progress 24rsv vaccine 25product description 25 ...

About 800 reports for Influenza Vaccine

Download Unlimited Documents from Trusted Public Sources

Vaccine Supply in the US

  • February 2013
    27 pages
  • Vaccine  

    Influenza Vacci...  

    Influenza  

  • United States  

View report >

1 Companies for Influenza Vaccine

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.